Accretion Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
ACCPL
Pharmaceuticals
Screen Accretion Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹97.65 Cr.
P/B Ratio
2.15
EPS (TTM)
₹8.48
Dividend Yield
-
Debt to Equity
1.33
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹40.00
Total Equity
₹15.00
Accretion Pharmaceuticals Share Price History - Stock Screener Chart
Screen ACCPL historical share price movements with interactive charts. Analyze price trends and patterns.
Accretion Pharmaceuticals Company Profile - Fundamental Screener
Screen Accretion Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ACCPL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0T8T01010
Accretion Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ACCPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Total Assets | 40 | 27 |
| Current Assets | 34 | 22 |
| Fixed Assets | 6 | 5 |
| Liabilities | ||
| Total Liabilities | 40 | 27 |
| Current Liabilities | 1 | 7 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 15 | 6 |
| Share Capital | 8 | 4 |
| Reserves & Surplus | 7 | 2 |
Screen ACCPL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March |
|---|---|---|---|
| Revenue | 0 | 58 | 13 |
| Expenses | 0 | 46 | 11 |
| EBITDA | 0 | 12 | 3 |
| Operating Profit % | 0.00% | 21.00% | 20.00% |
| Depreciation | 0 | 1 | 0 |
| Interest | 0 | 1 | 1 |
| Profit Before Tax | 0 | 10 | 2 |
| Tax | 0 | 3 | 1 |
| Net Profit | 0 | 7 | 2 |
| EPS | 0.00 | 8.48 | 11.08 |
Accretion Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen ACCPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 6 | -12 |
| Investing Activities | -2 | -6 |
| Financing Activities | -4 | 17 |
| Net Cash Flow | 0 | 0 |
Screen ACCPL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Jan | 2025-May | 2025-Jun | 2025-Sept | 2024-Sept |
|---|---|---|---|---|---|
| Promoter Holding | 100.00% | 73.50% | 73.50% | 73.52% | 100.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 0.00% | 19.44% | 21.46% | 22.85% | 0.00% |
| Other Holding | 0.00% | 7.06% | 5.04% | 3.63% | 0.00% |
| Shareholder Count | 8 | 8 | 1,628 | 1,498 | 8 |
Accretion Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen ACCPL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Accretion Pharmaceuticals Index Membership - Market Screener Classification
Screen ACCPL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Accretion Pharmaceuticals Market Events Screener - Corporate Actions
Screen ACCPL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 16.56% |
| 2025-06-11 | 2025-06-11 | Quarterly Result Announcement | NA | 5.68% |
Accretion Pharmaceuticals Competitors Screener - Peer Comparison
Screen ACCPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,614 | 39.35 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 169,847 | 68.64 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 130,301 | 60.42 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 122,079 | 22.17 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 106,248 | 18.42 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 96,362 | 21.87 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 92,005 | 18.03 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 90,673 | 50.11 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,709 | 20.16 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,838 | 26.89 | 13,458 | 3.70% | 2,216 | 37.45 |
Accretion Pharmaceuticals Company Announcements - News Screener
Screen ACCPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.